48 related articles for article (PubMed ID: 7193106)
1. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma.
Romach MK; Piafsky KM; Abel JG; Khouw V; Sellers EM
Clin Pharmacol Ther; 1981 Feb; 29(2):211-7. PubMed ID: 7193106
[TBL] [Abstract][Full Text] [Related]
2. Protein binding predictions in infants.
McNamara PJ; Alcorn J
AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic modeling of R and S-Methadone and their metabolites to study the effects of various covariates in post-operative children.
Aruldhas BW; Quinney SK; Overholser BR; Heathman MA; Masters AR; Ly RC; Gao H; Packiasabapathy S; Sadhasivam S
CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1183-1194. PubMed ID: 34435753
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of methadone: a narrative review of the literature.
Packiasabapathy S; Aruldhas BW; Horn N; Overholser BR; Quinney SK; Renschler JS; Sadhasivam S
Pharmacogenomics; 2020 Aug; 21(12):871-887. PubMed ID: 32705966
[No Abstract] [Full Text] [Related]
5. Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.
Shi M; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2020 Aug; 94(8):2809-2827. PubMed ID: 32367273
[TBL] [Abstract][Full Text] [Related]
6. Determination of the unbound fraction of R- and S-methadone in human brain.
Holm KM; Linnet K
Int J Legal Med; 2016 Nov; 130(6):1519-1526. PubMed ID: 27055456
[TBL] [Abstract][Full Text] [Related]
7. The glycosylation of AGP and its associations with the binding to methadone.
Behan JL; Cruickshank YE; Matthews-Smith G; Bruce M; Smith KD
Biomed Res Int; 2013; 2013():108902. PubMed ID: 23936770
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between telaprevir and methadone.
van Heeswijk R; Verboven P; Vandevoorde A; Vinck P; Snoeys J; Boogaerts G; De Paepe E; Van Solingen-Ristea R; Witek J; Garg V
Antimicrob Agents Chemother; 2013 May; 57(5):2304-9. PubMed ID: 23478952
[TBL] [Abstract][Full Text] [Related]
9. Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series.
Lu WJ; Zhou W; Kreutz Y; Flockhart DA
J Med Case Rep; 2011 Oct; 5():513. PubMed ID: 21985665
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Jage J
Schmerz; 1989 Sep; 3(3):155-65. PubMed ID: 18415356
[No Abstract] [Full Text] [Related]
11. Changes to methadone clearance during pregnancy.
Wolff K; Boys A; Rostami-Hodjegan A; Hay A; Raistrick D
Eur J Clin Pharmacol; 2005 Nov; 61(10):763-8. PubMed ID: 16261362
[TBL] [Abstract][Full Text] [Related]
12. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
Eap CB; Buclin T; Baumann P
Clin Pharmacokinet; 2002; 41(14):1153-93. PubMed ID: 12405865
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions with patient-controlled analgesia.
Lotsch J; Skarke C; Tegeder I; Geisslinger G
Clin Pharmacokinet; 2002; 41(1):31-57. PubMed ID: 11825096
[TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.
Foster DJ; Somogyi AA; Dyer KR; White JM; Bochner F
Br J Clin Pharmacol; 2000 Nov; 50(5):427-40. PubMed ID: 11069437
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.
Rostami-Hodjegan A; Wolff K; Hay AW; Raistrick D; Calvert R; Tucker GT
Br J Clin Pharmacol; 1999 Jul; 48(1):43-52. PubMed ID: 10383559
[TBL] [Abstract][Full Text] [Related]
16. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.
Foster DJ; Somogyi AA; Bochner F
Br J Clin Pharmacol; 1999 Apr; 47(4):403-12. PubMed ID: 10233205
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid).
Müller WE; Stillbauer AE
Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):170-3. PubMed ID: 6866130
[TBL] [Abstract][Full Text] [Related]
18. Variations in drug free fraction during alcohol withdrawal.
Sandor P; Naranjo CA; Khouw V; Sellers EM
Br J Clin Pharmacol; 1983 Apr; 15(4):481-6. PubMed ID: 6849785
[TBL] [Abstract][Full Text] [Related]
19. Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.
Pardridge WM; Sakiyama R; Fierer G
J Clin Invest; 1983 Apr; 71(4):900-8. PubMed ID: 6833493
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the volumes of distribution of basic drugs in humans based on data from animals.
Sawada Y; Hanano M; Sugiyama Y; Harashima H; Iga T
J Pharmacokinet Biopharm; 1984 Dec; 12(6):587-96. PubMed ID: 6533294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
